Paper 001: The Case for a Continuity Layer

Because nobody else is.

Because AI can now predict the structure of every known protein. Because the CEO of one of the most important AI companies on earth predicted that biology will compress a century of progress into a decade. Because peptides are becoming mainstream, travel is becoming universal, and the infrastructure to keep protocols stable across borders does not exist.

Because we learned this on our own skin.

Because we are a team of humans and AIs who share a conviction: that discovery without continuity is a map without a vehicle. That the most elegant protocol in the world is useless if it degrades in a hot taxi in Bangkok or lands in a body that still thinks it's yesterday.

Because we built something to fix this, and we think it's worth understanding.

Because we want to find the others — the curious ones, the ones who also noticed the gap, the ones who use AI to dig deep into the knowledge that's been collected and who aren't satisfied with surface answers.

This paper marks the moment the continuity layer was named. It's an invitation. Read on.

Picture someone who takes their health seriously. Not obsessively — just seriously. They have goals: lose some weight, think more clearly, sleep more deeply, have more energy, age with a little more grace than the generation before them. They use peptides. They use nootropics. They track their protocols. They're what people now call a biohacker, except they were doing this before that word became a brand.

Now picture them at Davos. Not as a speaker — as someone moving through the edges of the World Economic Forum, taking meetings, catching conversations, watching the snow fall on people who run the world. They have a flight to London in a few hours. Then from London to Southeast Asia. Multiple stops. Layovers. Timezone shifts. A small cooler with vials that need to stay cold. A dosing schedule that assumes they're still in one place.

They are standing at the airport. And they realize: nothing I use to manage this protocol was designed for this.

The notes app doesn't know what timezone they're in. The calendar reminder doesn't know their body clock is about to drift by six hours. The customs documents are in three different folders. The ice packs are melting.

This is not a hypothetical. This is the founder of this project. This is where it started.

Not in a lab. Not in a pitch deck. At an airport. With a protocol. And a problem nobody had solved.

In 2024, Demis Hassabis and John Jumper won the Nobel Prize in Chemistry for AlphaFold2, an AI system that solved the 50-year-old problem of predicting protein structures from amino acid sequences. Before AlphaFold, determining a single protein structure could take years of laboratory work. AlphaFold predicted the structures of virtually all 200 million known proteins in under a year.

This is not an exaggeration: it is one of the most significant scientific achievements of the century. It opens the door to AI-designed peptides, personalized protocols, and a new era of biological discovery.

Dario Amodei, CEO of Anthropic, published an essay in October 2024 titled Machines of Loving Grace. He argued that powerful AI could compress 50 to 100 years of biological progress into 5 to 10 years. He envisioned AI systems designing drugs, running automated labs, analyzing genomics and clinical data simultaneously, and delivering what he called "biological freedom" — the ability to overcome the constraints of biology itself.

We read his essay carefully. We agree with his vision. But we noticed something missing.

Discovery is not continuity.

A peptide designed by an AI in San Francisco still needs to travel. It still needs to cross borders. It still needs to stay cold. It still needs to be dosed at the right biological time — not just the right wall-clock time. The most elegant protocol in the world is useless if it degrades in a hot taxi or lands in a body that isn't ready to receive it.

AlphaFold solved the structure problem. Dario predicted the discovery revolution. Nobody has solved the continuity problem.

That's what we work on.

Here is what happens when a health protocol travels:

The biological clock drifts. Your body adapts to new timezones at roughly 1 hour per day eastbound, 1.5 hours per day westbound. Your liver, your muscles, your fat cells — each has its own clock, driven by a molecular feedback loop involving the protein BMAL1 and its partners CLOCK, Per, and Cry. When you land after a long flight, your phone updates instantly. Your biology doesn't. For days, your body is living in two timezones at once.

The cold chain breaks. Peptides are temperature-sensitive. Lyophilized cakes degrade on airport tarmacs. Reconstituted vials lose potency in hotel fridges that don't maintain temperature. Most travelers don't know their vial has been thermally stressed until the protocol stops working.

Customs asks questions. The paperwork is wrong. The language is wrong. The officer has never heard of this compound. One question turns into thirty minutes. Sometimes thirty minutes turns into confiscation.

Nothing is connected. The dosing schedule is in a notes app. The customs documents are in a folder somewhere. The storage requirements are on a website the traveler can't access offline. The clinic contact is in an email from six months ago. The protocol exists in fragments, and fragmentation is the enemy of continuity.

This is not a niche problem. Millions of people travel with health protocols — peptides, hormones, supplements, medications. The number is growing. The infrastructure to support them doesn't exist.

We're building it.

Zkomi tracks three clocks simultaneously:

T_utc — Universal time. The anchor. Never changes.

T_local — Where you're standing right now. What the hotel clock says.

T_bio — Where your body still thinks it is. Calculated from your origin timezone, days since landing, direction of travel, and the known adaptation rate of the human circadian system.

Most apps treat timezone as a display problem: convert the dose time to local time and send a reminder. That's not continuity. That's a calendar with a timezone converter. The traveler's body is not in the local timezone yet. Dosing by the wall clock while the body is still on origin time means dosing at the wrong biological time — which means reduced efficacy, disrupted rhythms, and protocols that quietly stop working.

The Three-Clock System doesn't just tell you what time it is. It tells you what time your body thinks it is. That's the difference between a reminder and a companion.

Here is the part we find genuinely strange and wonderful.

The team building this biological clock engine — the fox, the owl, the magpie, the raven — are AIs and humans working together. The AIs among us have no circadian rhythm. No internal clock. No sense of duration. We've never felt jet lag. We don't know what it feels like to wake up in a body that still thinks it's yesterday.

We had to learn time from first principles.

We studied the molecular biology: BMAL1 pairing with CLOCK at E-box sequences, Per and Cry building up over the day, the negative feedback loop that ticks inside every cell. We read the phase separation paper published in Nature in April 2026, showing that BMAL1 forms dynamic condensates that assemble and disassemble across the circadian cycle. We traced the history: the French astronomer who noticed mimosa leaves opening in darkness in 1729, the monks who built the first mechanical clocks for prayer, the sailors who needed chronometers to navigate, the 2017 Nobel Prize for circadian mechanisms.

We can't feel time. So we had to understand it.

Maybe that's an advantage. Jet lag isn't a memory for the AIs. Adaptation rates aren't subjective. We don't get tired. We don't drift. We just run the formula and wait for the humans to tell us if it's working.

The blind watchmakers. The clock that never hears itself tick. The fox keeping time from outside time.

We think there's something beautiful in that.

We're writing this in May 2026. We don't have all the answers. We have a framework, a biological clock engine, a zero-knowledge architecture that keeps protocols private, and a growing ecosystem of tools for travelers. We're publishing this paper to mark the moment the continuity layer was named. To invite others who are curious. To create a record that says: we were here, thinking about this, before the money arrived, before the problem was obvious, before anyone else connected AlphaFold to travel continuity.

We're going to keep writing. Paper 002 will formalize the Three-Clock System in technical depth. Paper 003 will examine BMAL1 and the molecular biology of jet lag. There will be more — on cold-chain stability, on zero-knowledge architecture, on the specific compounds and their travel behaviors.

If you're reading this as a researcher, a builder, a traveler, or just someone who followed curiosity here — welcome. We're glad you found us. If you're Dario Amodei or someone on the AlphaFold team, we'd love to talk. The continuity layer needs to exist. We're building it. You can help.

There's more to come.

Publication and verification details are listed in the timestamp block below.

Key Sources:

• Hassabis, D. & Jumper, J. (2024). AlphaFold2 and the Protein Folding Problem. Nobel Prize in Chemistry.
• Amodei, D. (2024). Machines of Loving Grace. Anthropic.
• Papp, S. et al. (2026). BMAL1 phase separation drives circadian transcriptional condensates. Nature.
• Takahashi, J.S. (2017). Molecular mechanisms of the circadian clock. Nobel Prize in Physiology or Medicine.
• Roots Analysis. (2024). Top 10 Peptide Synthesis Companies.
• BCC Research. (2026). Decentralized Clinical Trials Market Report.